cdmo.directory
← Compare landing

Grifols Partnership vs ReAgent Chemical Services

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/grifols/reagent-co

CategoryGrifols PartnershipReAgent Chemical Services
Listed sitecdmocdmo
SummaryCDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise.UK-based contract chemical manufacturer since 1977, offering bespoke synthesis, formulation development, filling, and repacking services across pharma, industrial, and specialty chemical sectors.
Services
  • Formulation Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Process Development
  • Small Molecule Development & Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
  • Vial Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Formulation Development
  • Process Development
  • Secondary Packaging & Labeling
  • Quality Control Testing
  • CMC Analytical Development
Modalities
  • Biologics (Other)
  • Small Molecule
  • Small Molecule
Indications
  • Immunology
  • Neurology
  • Cardiovascular
  • Infectious Disease
  • Respiratory
Data not yet provided.
Locations
  • Headquarters, Sant Cugat del Vallès, Catalonia, Spain
  • Headquarters & Manufacturing Facility, Runcorn, Cheshire, United Kingdom
  • Headquarters, Runcorn, Cheshire, United Kingdom
CertificationsData not yet provided.
  • ISO · Identifier: ISO 9001:2008
  • ISO · Identifier: ISO 14001:2004
  • ISO · Identifier: ISO 13485:2016
  • ISO · Identifier: ISO 45001:2018
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.